Injected trivalent inactivated influenza vaccines are most commonly used throughout the world. Influenza antigen preparation varies between manufacturers.
In 2024, and as of 31 of January, approximately 10 000 CHIKVD cases and no deaths have been reported worldwide. A total of eight countries reported CHIKVD cases from the America (6) and Asia (2).